Boenning & Scattergood’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-760
| Closed | -$203K | – | 403 |
|
2022
Q3 | $203K | Buy |
+760
| New | +$203K | 0.04% | 349 |
|
2021
Q4 | – | Sell |
-760
| Closed | -$215K | – | 392 |
|
2021
Q3 | $215K | Sell |
760
-100
| -12% | -$28.3K | 0.04% | 350 |
|
2021
Q2 | $298K | Sell |
860
-329
| -28% | -$114K | 0.05% | 308 |
|
2021
Q1 | $333K | Buy |
1,189
+294
| +33% | +$82.3K | 0.06% | 281 |
|
2020
Q4 | $219K | Sell |
895
-35
| -4% | -$8.56K | 0.05% | 312 |
|
2020
Q3 | $264K | Buy |
930
+60
| +7% | +$17K | 0.06% | 269 |
|
2020
Q2 | $233K | Sell |
870
-100
| -10% | -$26.8K | 0.06% | 274 |
|
2020
Q1 | $307K | Hold |
970
| – | – | 0.11% | 198 |
|
2019
Q4 | $288K | Buy |
970
+70
| +8% | +$20.8K | 0.07% | 247 |
|
2019
Q3 | $210K | Hold |
900
| – | – | 0.06% | 253 |
|
2019
Q2 | $211K | Hold |
900
| – | – | 0.06% | 257 |
|
2019
Q1 | $212K | Buy |
900
+200
| +29% | +$47.1K | 0.06% | 265 |
|
2018
Q4 | $211K | Sell |
700
-100
| -13% | -$30.1K | 0.07% | 241 |
|
2018
Q3 | $282K | Sell |
800
-530
| -40% | -$187K | 0.09% | 221 |
|
2018
Q2 | $386K | Buy |
+1,330
| New | +$386K | 0.13% | 192 |
|